SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-125827
Filing Date
2018-04-23
Accepted
2018-04-23 07:01:04
Documents
4
Period of Report
2018-04-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d576174d8k.htm 8-K 15377
2 EX-99.1 d576174dex991.htm EX-99.1 1327
3 GRAPHIC g576174ex99_1s1g1.jpg GRAPHIC 146231
4 GRAPHIC g576174ex99_1s2g1.jpg GRAPHIC 182705
  Complete submission text file 0001193125-18-125827.txt   471026
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 18767908
SIC: 2834 Pharmaceutical Preparations